n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with HbS Disease in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, GD | 1 |
| Jensen-Pergakes, K | 1 |
| Wilkey, C | 1 |
| Jhaveri, U | 1 |
| Richard, N | 1 |
| Verhelle, D | 1 |
| De Parseval, LM | 1 |
| Corral, LG | 1 |
| Xie, W | 1 |
| Morris, CL | 1 |
| Brady, H | 1 |
| Chan, K | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and HbS Disease
| Article | Year |
|---|---|
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2.
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cyclooxygenase 2; C | 2007 |